Effect of cariprazine on attention and quality of life in patients with predominant negative symptoms of schizophrenia: A post-hoc analysis
This post-hoc analysis suggests that cariprazine may be associated with beneficial effects on measures of attention and QoL among patients with schizophrenia, and these effects could be more pronounced among individuals with PNS.
Authors
- Lisa Buchy
- C. Di Cresce
- Philip G. Tibbo (ORCID: https://orcid.org/0000-0002-2070-6495)
- Oloruntoba Oluboka
- Andrea Bardell
- Howard C. Margolese (ORCID: https://orcid.org/0000-0002-3912-0566)
- Roger S. McIntyre (ORCID: https://orcid.org/0000-0003-4733-2523)
- Jun Yu (ORCID: https://orcid.org/0009-0006-3920-9321)
Institutions
- Dalhousie University (CA)
- University of British Columbia (CA)
- University of Calgary (CA)
- University of Toronto (CA)
- Ottawa Hospital (CA)
- AbbVie (United States) (US)
- ABB (Canada) (CA)
- McGill University (CA)
Publication Details
- Journal
- Schizophrenia Research Cognition
- Published
- 2025-03-08
- DOI
- https://doi.org/10.1016/j.scog.2025.100355
- Citations
- 1
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.47